Knowledge Library Prototype
Cardiology Intelligence
Prototype collection covering cardiovascular therapeutics, hypertension, heart failure, lipid management, anticoagulation, diabetes-related cardiovascular risk, FDA updates, clinical trials, and AJPPS research.
Featured AJPPS Research
Placeholder for AJPPS cardiovascular, hypertension, pharmacotherapy, and outcomes research.
Latest Cardiology Intelligence
Reserved for approved RSS/API content relevant to pharmacists, pharmaceutical scientists, clinicians, educators, and students.
FDA & Regulatory Updates
- BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
by FDA on 07/24/2026 at 9:46 pmJuly 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard. Risk Statement: The use of the defective product has a
- Generic Drug User Fee Amendmentsby FDA on 07/24/2026 at 8:48 pm
This page features news and information for industry and stakeholders about GDUFA, its fee structure, payment methods, and related information.
- Generic Drug Facilities, Sites and Organization Listsby FDA on 07/24/2026 at 7:06 pm
Generic Drug Facilities, Sites and Organization Lists
- Oncology (Cancer)/Hematologic Malignancies Approval Notificationsby FDA on 07/24/2026 at 7:03 pm
FDA does not issue approval announcements for every approval or drug label update that occurs in oncology and hematology. Please refer to Drugs@FDA for the latest approvals and prescribing information for specific products.
- What's New Related to Drugsby FDA on 07/24/2026 at 6:56 pm
Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.
Clinical Trials Watch
Future ClinicalTrials.gov integration for hypertension, heart failure, lipid disorders, anticoagulation, and cardiometabolic disease.
Clinical Practice & Therapeutics
Future summaries should connect evidence updates to pharmacy practice, medication safety, guideline changes, and patient counseling.
Related Collections
- Diabetes & Cardiometabolic Intelligence
- FDA Approvals & Medication Safety
- Pharmacogenomics Intelligence